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DOI 10.1016/j.ccr.2012.03.044SUMMARYHuman cancers with a subtetraploid karyotype are thought to originate from tetraploid precursors, but the
cause of tetraploidization is unknown. We previously documented endoreduplication in mouse cells with
persistent telomere dysfunction or genome-wide DNA damage. We now report that endoreduplication and
mitotic failure occur during telomere crisis in human fibroblasts and mammary epithelial cells and document
the role of p53 and Rb in repressing tetraploidization. Using an inducible system to generate transient telo-
mere damage, we show that telomere-driven tetraploidization enhances the tumorigenic transformation of
mouse cells. Similar to human solid cancers, the resulting tumors evolved subtetraploid karyotypes. These
data establish that telomere-driven tetraploidization is induced by critically short telomeres and has the
potential to promote tumorigenesis in early cancerous lesions.INTRODUCTION
Aneuploidy is a general feature of human solid tumors. An impor-
tant source of aneuploidy is an elevated rate of chromosome
mis-segregation (Lengauer et al., 1997). However, a substantial
fraction of tumors have very high chromosome numbers, ranging
from hypertriploid to subtetraploid, making it unlikely that
nondisjunction of individual chromosomes is the sole mecha-
nism responsible for their abnormal karyotypes (reviewed in
Ganem et al., 2007; Storchova and Kuffer, 2008; Davoli and
de Lange, 2011). More likely, these tumors arise from an initial
tetraploidization event that is followed by frequent chromosome
loss (Shackney et al., 1989). Indeed, tetraploid nuclei and super-
numerary centrosomes have been noted in the early stages of
some solid tumors (Reid et al., 1996; Kirkland et al., 1967). Impor-
tantly, tetraploidization after chemically induced cytokinesis
failure has been shown to promote tumorigenesis in p53-
deficient mouse mammary epithelial cells (Fujiwara et al., 2005).
Potential sources of tetraploidization in cancer are mutations
in the tumor suppressor Adenomatous Polyposis Coli or dereg-
ulation of mitotic factors such as Mad2, Emi1, LATS1, and
AuroraA (Davoli and de Lange, 2011). An additional mechanismSignificance
Tetraploidization can occur early in tumorigenesis and is thoug
karyotypes with high chromosome numbers. Here, we show tha
blasts and mammary epithelial cells enter telomere crisis. Mou
tion have an increased transformation potential. These finding
and point to the importance of telomere dysfunction in shapinfor the duplication of cancer genomes was suggested by the
frequent tetraploidization in mouse cells experiencing telomere
dysfunction (de Lange, 2005; Hockemeyer et al., 2006; Davoli
et al., 2010; Kibe et al., 2010). In these experiments, telomere
dysfunction was induced by removing the shelterin proteins
POT1a and POT1b from the telomeres of p53-deficient mouse
embryo fibrobloasts (MEFs). The resulting ataxia telangiectasia-
and Rad3-related (ATR) signaling forestalls the activation of
Cdk1/CyclinB, blocking entry into mitosis. However, after a pro-
longed period in G2, the replication inhibitor geminin is degraded
and the licensing factor Cdt1 is re-expressed allowing the cells to
re-enter S phase, resulting in endoreduplication. Endoreduplica-
tion and tetraploidy are also induced by continuous treatment of
p53-deficient MEFs with genotoxic drugs, indicating that the en-
docycles are due to the persistence of the DNA damage signal
rather than its origin.
We have proposed that the telomere-dependent pathway for
tetraploidization is relevant to human cancer because telomere
attrition is widespread during tumorigenesis (de Lange et al.,
1990; Hastie et al., 1990; Meeker et al., 2002, 2004; van Heek
et al., 2002; Meeker and Argani, 2004). Due to the absence of
telomerase (Kim et al., 1994), telomeres shorten with cellht to be responsible for the emergence of aneuploid cancer
t tetraploidy is inducedwhen human p53/Rb-deficient fibro-
se cells that have become tetraploid after telomere dysfunc-
s can explain how tetraploidization occurs in human cancer
g cancer genomes.
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Telomere Crisis Induces Tetraploidizationdivisions in most human somatic cells, including cells under-
going the first stages of tumorigenic transformation. After exten-
sive proliferation, dysfunctional short telomeres are recognized
as sites of DNA damage by the ATM and ATR kinases and induce
p53/Rb-mediated senescence or apoptosis (d’Adda di Fagagna
et al., 2003; Herbig et al., 2004). In the absence of p53 and Rb
function, cells continue to proliferate despite the presence of
dysfunctional telomeres (Wright and Shay, 1992; Shay and
Wright, 2005). Eventually, the cells enter telomere crisis, a stage
in which the rampant genome instability associated with lack of
telomere function curbs cell proliferation and survival (Wright and
Shay, 1992; Shay et al., 1993; Shay and Wright, 2005; Counter
et al., 1992).
There is mounting evidence that prior to the activation of
telomerase, developing cancers can experience a period of
telomere crisis (Meeker et al., 2004; de Lange, 2005). Molecular
analysis of chronic lymphocytic leukemia has revealed evidence
for telomere fusions, a product of telomere crisis (Lin et al., 2010).
Furthermore, telomere crisis was inferred to occur in the ductal
carcinoma in situ (DCIS) stage of breast cancer based on the
presence of short telomeres and an abrupt rise in genome
instability before telomerase is activated (Chin et al., 2004).
Modeling in the mouse has provided evidence that the genome
instability arising in telomere crisis can promote tumorigenesis
in a permissive setting (Artandi and DePinho, 2010; Artandi
et al., 2000).
Here, we investigate the frequency and mechanism of
tetraploidization in human fibroblasts and epithelial cells under-
going telomere crisis. FUCCI imaging for geminin and Cdt1 re-
vealed that tetraploidization was due to both mitotic failure and
endoreduplication. Moreover, using mouse cells we show that
tetraploidization-induced by telomere dysfunction can promote
tumorigenesis, as is the case for tetraploidization induced by
cytokinesis inhibitors (Fujiwara et al., 2005). The resulting tumors
have a chromosome complement reminiscent of the subtetra-
ploid karyotypes of human solid tumors. These data are con-
sistent with a role for telomere dysfunction in the induction of
tetraploidy in the early stages of human tumor development.
RESULTS
Tetraploidization in Telomere Crisis
To generate cells in telomere crisis, telomerase-negative human
IMR90 and BJ fibroblasts were rendered p53- and Rb-deficient
through expression of SV40 large T antigen (SV40-LT). As ex-
pected, the telomeres shortened progressively in these cultures
(Figure 1A), resulting in telomere crisis at population doubling
(PD) 80–90 for IMR90-SV40LT and at PD 105–110 for BJ-
SV40LT. Telomere crisis was evident from the plateau in the
growth curve (Figure 1B), the increased number of 53BP1 DNA
damage foci (Figure 1C), and the phosphorylation of Chk1 and
Chk2 (Figure 1D). Fluorescence-activated cell sorting (FACS)
analysis showed that the fraction of tetraploid cells (estimated
based on the fraction of cells with a DNA content >4N) progres-
sively increased from 2%–3% at early PDs to 30%–35% at the
time of telomere crisis (Figure 1E). Similarly, BJ fibroblasts trans-
formed by HPV E6 and E7 displayed hallmarks of telomere crisis
and accompanying tetraploidization at PD 90–100 (Figures
S1A–S1D available online).766 Cancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc.Telomere crisis was also induced in two telomerase-negative
human mammary epithelial cell strains (hMECs), 184B-GSE22
and 48RS-GSE22, which lack a functional Rb pathway and
express the p53 inhibitory peptide GSE22 (Romanov et al.,
2001; Garbe et al., 2007). When these cells divide beyond senes-
cence, they continue to erode their telomeres and enter a telo-
mere crisis that is accompanied by genome instability (Romanov
et al., 2001). The p53-proficient 184B and 48RS precursors were
used as controls. The 184B-GSE22 and 48RS-GSE22 cultures
entered telomere crisis at passage 18-20 and passage 28-32,
respectively, showing shortened telomeres, an increase in the
frequency of 53BP1 foci, and phosphorylation of Chk1 and
Chk2 (Figures 2A and 2B; Figures S2A and S2B). FACS analysis
showed an increase in the fraction of cells with >4N DNA content
upon entry into telomere crisis in the two p53/Rb-negative
hMEC cultures, whereas the parallel p53-proficient counterparts
showed a G1/S arrest without tetraploidization (Figures 2C
and 2D). Tetraploidization in telomere crisis was confirmed by
analyzing the chromosome numbers of metaphase spreads (Fig-
ureS2C). TheGSE-22expressing hMECs, but not their p53-profi-
cient counterparts, showed evidence for tetraploidization when
precrisis cultures were treated with zeocin for 96 hr (Figures 2E
and 2F).
Thus, in epithelial cells as well as in fibroblasts, telomere crisis
and prolonged genome-wide DNA damage is accompanied by
polyploidization resulting in tetraploid cells. While the formation
of tetraploid cells is readily demonstrable, we note that the 8N
peak in the FACS profiles of cells in crisis could represent octo-
ploid cells in G1 as well as tetraploid cells in G2. As two succes-
sive aberrant cell cycles are required to generate octoploid cells,
octoploidization might be too infrequent to result in a clear 16N
peak in the FACS profiles.
Endoreduplication and Mitotic Failure in Telomere
Crisis
The increased ploidy of cells in telomere crisis could be due to
either endoreduplication or a failure in the late stages of mitosis,
since dicentrics formed by telomere fusions (Figure S2D) hinder
the completion of cytokinesis. To distinguish between these
events, we performed live-cell imaging using the FUCCI system
(Sakaue-Sawano et al., 2008), which previously demonstrated
endoreduplication in POT1a/b DKO cells (Davoli et al., 2010).
FUCCI is based on the cell cycle dependent expression of fluo-
rescently tagged fragments of Cdt1 and geminin. The licensing
factor Cdt1, which mediates the formation of prereplication
complexes, is expressed in G1 and degraded upon entry into
S phase in a process that is coupled to DNA replication (Arias
and Walter, 2005; Remus and Diffley, 2009). Cdt1 is further in-
hibited by geminin, which is expressed in S/G2. In a normal
mitotic cycle, geminin is degraded during mitosis, thereby re-
establishing a state that is permissive to origin licensing in the
daughter cells. However, in cells undergoing telomere-driven en-
doreduplication, geminin degradation takes place in the absence
of mitosis, allowing cells to enter a G1-like state in which Cdt1
can mediate a second round of DNA replication. Thus, mitosis-
independent geminin degradation is an indicator for endoredu-
plication (Figures 3A and 3B; Movie S1). In addition, FUCCI
imaging can be used to detectmitotic failure based on the break-
down of the nuclear envelope that signifies entry into mitosis and
Figure 1. Tetraploidization of BJ-SV40 and IMR90-SV40 in Telomere Crisis
(A) Genomic blot for telomere restriction fragments of SV40-LT transformed IMR90 and BJ human fibroblasts at the indicated PD.
(B) Growth curve of IMR90-SV40 and BJ-SV40 from PD 20 or 38, respectively, until crisis (105–110 PDs for BJ-SV40 cells and at 80–90 for IMR90-SV40).
(C) IF analysis of 53BP1 foci in the cells at the indicated PDs. The average number of 53BP1 foci per cell and the percentage of cells with more than three foci are
shown with SD. Scale bar = 5 mm.
(D) Immunoblots for P-Chk1 and P-Chk2 in the BJ-SV40 and IMR90-SV40 cells at the indicated PD.
(E) FACS profiles (PI staining) of IMR90-SV40 and BJ-SV40 cells indicated PD. The percentage of cells with >4N DNA content is indicated.
See also Figure S1.
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Telomere Crisis Induces Tetraploidizationthe binucleated ormultinucleated cells that result from a failure in
cytokinesis (Figures 3A and 3B; Movie S1).
As expected, FUCCI imaging at early PDs (PD < 50) of BJ-
SV40 and BJ-E6/E7 fibroblasts showed that in most cells gemi-
nin degradation coincided withmitosis, whereas endocycles and
mitotic failure were rare (<5%) (Figures 3A–3C; Movie S1).
However, at the late PDs when the cells entered telomere crisis,
the fraction of BJ-SV40, BJ-E6E7 and IMR90-SV40 cells under-
going geminin degradation in the absence of mitosis increased
to 12%–17% (Figures 3A–3C; Figure S3; Movies S1 and S2).
After loss of geminin, most of these cells expressed Cdt1 and
entered a second S phase as deduced from the degradation of
Cdt1 and reappearance of geminin. During these endocyclesthere was no evidence of nuclear envelope breakdown. The
BJ-SV40 fibroblasts in telomere crisis also displayed aprolonged
S/G2 phase whereas G1 was only minimally affected (Fig-
ure 3D; Movie S1). In addition, the cells showed occasional
metaphase spreads with diplochromosomes, a characteristic
consequence of endoreduplication representing duplicated
sister chromatids that are held together by the centromeric co-
hesin (Figure S2D).
In addition to endoreduplication, fibroblasts in telomere crisis
showed a considerable level of mitotic failure (Figures 3A–3C;
Figure S3; Movies S1 and S2). Their aberrant mitosis was
presumably due to the dicentric chromosomes resulting from
telomere fusions (Figure S2D). The cells attempted mitosis asCancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc. 767
Figure 2. Tetraploidization of hMECs in Telomere Crisis
(A) IF for 53BP1 foci in 184B-GSE22 and 48RS-GSE22 hMECs at the indicated passage. The average number of 53BP1 foci per nucleus and the percentage of
cells with more than three foci are given with standard deviation. Scale bar = 5 mm.
(B) Immunoblots for Chk1 and Chk2 phosphorylation in 48RS-GSE22 and 184B-GSE22 at the indicated passage and after zeocin treatment.
(C and D) FACS analysis of the indicated hMECs at the indicated passage. The percentage of cells with DNA content >4N is indicated. Quantification of averages
of two or three independent experiments is shown in (D).
(E and F) FACS analysis of 184B-GSE22 and 48RS-GSE22 at the indicated (early) passage treated with zeocin. The percentage of cells with a DNA content >4N is
indicated. Quantification of three independent experiments is shown in (F).
See also Figure S2.
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Telomere Crisis Induces Tetraploidizationevidenced by their rounding up and breakdown of the nuclear
envelope leading to the presence of geminin throughout
the cells. However, the execution of cytokinesis appeared to
fail, resulting in binucleated or multinucleated cells (Movies S1
and S2).
Endoreduplication and mitotic failure was also observed in the
hMEC lines 48RS-GSE22 and 184B-GSE22 in telomere crisis
and upon continuous treatment with zeocin (Figures 4A and
4B; Movie S3). Mitotic failure appeared to be more frequent in
the hMECs compared to the BJ and IMR90 fibroblasts. For
instance, in the presence of zeocin, BJ-SV40 fibroblasts pre-
dominantly show endoreduplication, whereas hMECs also
show mitotic failure events (Figures 4A and 4B; Movie S3; Davoli
et al., 2010; data not shown).768 Cancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc.Role of Rb in Blocking Telomere-Driven
Tetraploidization
In human cells, activation of the Rb pathway contributes to the
cell cycle arrest in response to a genome-wide or telomere-
derived DNA damage signal (Jacobs and de Lange, 2004;
Shay et al., 1991; Smogorzewska and de Lange, 2002; Shay
andWright, 2005). In order to determine whether the Rb pathway
can block tetraploidization, we analyzed telomerase-negative BJ
fibroblasts with an unaltered Rb pathway. The p53 dominant-
negative allele (p53 dn, p53175H) was used to abrogate the
p53 response to DNA damage (p53 dn, Baker et al., 1990;
Jacobs and de Lange, 2004).
To measure their propensity for tetraploidization, the BJ-p53
dn cells were either subjected to continuous zeocin treatment
Figure 3. Endoreduplication and Mitotic Failure in Telomere Crisis
(A and B) FUCCI live-cell imaging of BJ-SV40 cells at PD45 and PD105 analyzed by time-lapse every 20 min for 96 hr. (A) Enlarged images exemplifying
endoreduplication and mitotic failure. (B) Selected time points from Movie S1. Arrows with the same orientation highlight the same cell over time. In BJ-SV40 PD
45, the arrow highlights one cell progressing through a normal cell cycle. In BJ-SV40 cells PD 105, the white arrows highlight two cells undergoing endor-
eduplication; the black arrow highlights mitotic failure. Scale bar = 20 mm.
(C) Table summarizing the data derived from FUCCI imaging as in (B) (Movies S1 and S2) and FACS of BJ-SV40, IMR90-SV40, and BJ-E6E7. The average and SD
obtained from three independent experiments is given (n is the total number of cells analyzed in each case).
(D) BJ-SV40 cells at the indicated PDswere imaged as in (A). The indicated number of cells was followed during the imaging session and the duration (hours) of the
presence of geminin and Cdt1 was analyzed (average values are indicated).
See also Figure S3 and Movies S1 and S2.
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Telomere Crisis Induces Tetraploidizationor extensive replicative telomere shortening (PD 70–80; Figures
5A–5C; Figures S4A–S4C). As compared to PD 30, at PD 70–80
the BJ-p53 dn cells showed a small increase in the fraction of
tetraploid cells (<1% to 7%) (Figures 5A and 5B). The DNA
damage response was active in BJ-p53 dn cells at PD 70–80,
as shown by Chk1 phosphorylation and an increased numberof 53BP1 foci compared to earlier PDs (Figure 5C; Figure S4C).
FACS analysis indicated that BJ-p53dn showed fewer tetraploid
cells and a lower fraction of cells in G2 compared to BJ-SV40 at
the same PD (Figures 1E, 5A, and 5B). Furthermore, after 96 hr of
zeocin treatment, only 9% of BJ-p53dn cells had a DNA
content >4N (Figures 5A and 5B), whereas 20%–25% ofCancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc. 769
Figure 4. Endoreduplication and Mitotic Failure in hMECs in Telomere Crisis
(A) FUCCI imaging (as in Figures 3A and 3B) of 48RS-GSE22 at the indicated passages with or without zeocin treatment. Indicated time points are fromMovie S3.
Arrows with the same orientation highlight the same cell over time. In 48RS-GSE22 p32 and p20+zeocin, the white arrows highlight cells showing endor-
eduplication and the black arrows highlight cells undergoing mitotic failure. Scale bar = 20 mm.
(B) Table summarizing data derived from FUCCI imaging (Movie S3) and FACS (as in Figure 3C).
See also Figure S2 and Movie S3.
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Telomere Crisis Induces TetraploidizationBJ-SV40 became tetraploid after zeocin treatment (Figures 5A
and 5B; Davoli et al., 2010). Similar data were obtained using
IMR90 and RPE (retinal pigment epithelial) cells lacking p53
function (Figures S4D and S4E and data not shown), whereas
tetraploidy was not induced in primary RPE and BJ cells, which
arrested in G1/S (Figures S4D and S4E and data not shown).
Consistent with a role of the Rb pathway in mediating a
G1/S arrest in response to telomere and genome-wide DNA
damage, the level of p16 increased at increasing PDs and after
zeocin treatment (Figure 5C). These data suggest that the activa-770 Cancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc.tion of the Rb/p16 pathway contributes to the repression of
tetraploidization in cells experiencing a persistent DNA damage
response.
The low level of residual tetraploidization in the Rb-proficient
cells could be explained if the Rb pathway led to a block in G1
but not in G2. We therefore isolated FACS-sorted G1 and S/G2
cells, subjected them to zeocin treatment soon after plating,
and then used FUCCI imaging to determine their tendency to
undergo cell cycle progression and/or tetraploidization. Approx-
imately 60% of the G1-sorted BJ-p53dn cells treated with
Figure 5. Rb-MediatedG1Arrest Represses
Tetraploidization
(A) FACS analysis of BJ cells expressing p53175H
(p53 dn) or SV40-LT at the indicated PD with or
without treatment with zeocin.
(B) Quantification of the FACS data in (A) (as in
Figure 2D).
(C) Immunoblot for Chk1 phosphorylation and
p16 expression in BJ-p53 dn at the indicated PDor
after treatment with zeocin.
(D) FUCCI imaging of BJ-p53 dnPD 35 and BJ-
SV40 PD 40 cells that were first FACS sorted for
G1 (Cdt1, red) or S/G2 (geminin, green) and then
imaged in the presence of zeocin (Movies S4 and
S5). Selected time points are shown. Quantifica-
tion of the movies is shown below the images. The
number of cells that remain arrested in G1/S (red/
yellow color) throughout the imaging session and
the cells showing geminin degradation in the
absence of mitosis were scored in the indicated
cases. Average numbers obtained in two experi-
ments are shown.
See also Figure S4 and Movies S4 and S5. Scale
bar = 20 mm.
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Telomere Crisis Induces Tetraploidizationzeocin remained in G1/S phase of the cell cycle (red or yellow)
throughout the 96 hr imaging session (Figure 5D; Movie S4)
whereas only 25%–30% of G1-sorted BJ-SV40 cells arrestedCancer Cell 21, 765–7in G1/S after zeocin treatment (Figure 5D;
Movie S4). In contrast, approximately
75% of the BJ-p53dn S/G2 cells
underwent endoreduplication, showing
mitosis-independent geminin degrada-
tion and re-entry into G1 and S-phase
(Figure 5D; Movie S5). BJ-SV40 cells in
S/G2 showed the same percentage of en-
doreduplication, indicating that Rb status
does not affect tetraploidization of cells
experiencing prolonged DNA damage in
S/G2. Although we cannot exclude other
aspects of SV40 large T antigen expres-
sion, these data suggest that activation
of the Rb/p16 pathway blocks entry into
S phase in cells that experience a DNA
damage signal in G1, thereby limiting
the occurrence of tetraploidization. In
contrast, the Rb/p16 pathway alone is
not capable of preventing endoreduplica-
tion when the DNA damage takes place
in G2.
Telomere-Driven Tetraploidization
Promotes Transformation in Mouse
Cells
To address the tumorigenic potential of
tetraploidization, we used an inducible
system to elicit transient telomere
dysfunction, mimicking the temporary
loss of telomere protection that is thought
to occur early in tumorigenesis beforetelomerase activation. We employed the previously established
tet-OFF inducible system for POT1a expression in MEFs ex-
pressing SV40-LT (Davoli et al., 2010). Two POT1a-tetOFF cell76, June 12, 2012 ª2012 Elsevier Inc. 771
Figure 6. Telomere-Driven Tetraploidy
Promotes Cellular Transformation in Mouse
Cells
(A) Immunoblot for Chk1 phosphorylation and
POT1a in POT1a-tetOFF-19 and -26 cells (SV40-
LT expressing MEFs) at the indicated time after
treatment with doxycycline and after release of the
FACS-sorted diploid and tetraploid cells. POT1a-
tetOFF clones 19 and 26 (Davoli et al., 2010) were
treated with doxycycline for 10 days, FACS sorted
after Hoechst 33342 staining, and cultured in the
absence of doxycycline.
(B) FACS analysis of POT1a-tetOFF-19 and -26
treated as in (A). The percentage of cells with >4N
DNA content is indicated.
(C) POT1a-tetOFF-19 and -26 with or without
pBabe-Myc-ER were treated as in (A). FACS sor-
ted diploid and tetraploid cells were expanded for
2 weeks or for 6–8 weeks and plated in soft-agar.
The colonies were counted after 4–6 weeks. Myc-
ER was induced with 0.5 mM OHT. The average
number of colonies per well and SD obtained after
3 or 4 independent experiments is shown. Stars
indicate statistically significant difference (p < 0.05
after paired Student’s t test, Prism 5 software).
(D) Tumorigenicity assay in nudemice. Diploid and
tetraploid descendants of POT1a-tetOFF-19 and-
26 were expanded for 2 weeks or for 5–6 weeks in
culture in the absence of doxycycline subcutane-
ously injected in nude mice (2.5 or 5 10^5 cells
injected on each side; the number of injected mice
is shown). The average frequencies of tumor
formation and latencies are indicated with stan-
dard deviation (three or four experiments, five or
ten mice per experiment). Stars indicate a statisti-
cally significant difference (p < 0.05 after paired
Student’s t test).
See also Figure S5.
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with doxycycline transiently depletes POT1a. As expected from
previous data, the loss of POT1a was accompanied by the accu-
mulation of 53BP1 at telomeres, phosphorylation of Chk1
(Figures 6A and 6B; Figure S5A) and tetraploidization as
measured by FACS (Figure 6B). Tetraploidization was also
evident in these cells from the supernumerary centrosomes
and telomere clustering in interphase which are consistent with
chromosome reduplication without chromosome segregation
(Hockemeyer et al., 2006; Figures S5A and S5B). After doxycy-
cline treatment, POT1a-tetOFF-19 and -26 cells were FACS-
sorted based on Hoechst-staining for DNA content to derive
tetraploid and diploid cells (Figure S5C). The diploid and tetra-
ploid cells were cultured for either 2 or 5–6 weeks in the absence
of doxycycline, allowing POT1a re-expression (Figure 6A). The
results at these two time points were essentially the same.772 Cancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc.The resulting diploid and tetraploid
cultures were then tested for their ability
to form colonies in soft-agar and tumors
in nude mice (Figures 6C and 6D). For
both POT1a-tetOFF-19 and -26, the tetra-
ploid descendants were more trans-
formed based on both assays. The trans-formation efficiency after long-term culture (5–6 weeks) was
slightly higher than the one after short-term culture (2 weeks).
Overexpression of c-Myc further enhanced the transformation
of diploid and tetraploid POT1a-tetOFF cells but even without
this oncogene, the greater tumorigenic potential of the tetraploid
population was significant (Figures 6C and 6D). POT1atetOFF
control cells not treated with doxycycline transformed at a rate
similar to the sorted diploid cells (not shown). The increased
transformation potential in the tetraploid cells was not due to
increased proliferation rate, since the tetraploid cells grew slower
than their diploid counterparts (Figure S5D).
Evolution of Subtetraploid Karyotypes
In order to monitor the karyotypic changes during tumor
outgrowth, we established cell lines from tumors formed upon
injection of diploid and tetraploid mouse cells. Prior to injection
Figure 7. Evolution of Subtetraploid Karyotypes
(A and B) Graphs indicating the number of chromosomes/metaphase in cells
derived from tumors formed by diploid and tetraploid POT1a-tetOFF-19
and -26 cells (as in Figure 6D). Cell lines were derived from tumors and
metaphase spreads were analyzed after 7–10 days. The distribution of the
chromosome number of POT1a-tetOFF diploid and tetraploid cells before
injection and of cell lines derived from the indicated tumors derived from
injected diploid or tetraploid cells is shown.
(C) Graphs indicating the number of chromosomes/metaphase in cells derived
from soft-agar colonies formed POT1a-tetOFF-26 (as in Figure 6D).
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construct allowing separation of tumor cells from host-derived
cells present in the tumor mass. GFP-positive cells of tumors
derived from injected tetraploid cells showed a tetraploid-like
profile, consistent with their cells of origin (Figures S5E and
S5F). As expected, the host-derived GFP-negative cells showed
a diploid-like profile. A total of eight GFP-positive cell lines were
derived from tumors formed by the POT1a-tetOFF-19 and -26
tetraploid cells. Their chromosome numbers, determined after
propagation of the cells for 7–10 days in culture revealed subte-
traploid karyotypes, with the exception of one line which was
hyper-tetraploid (chromosome number 120, Figures 7A and
7B). Evolution of subtetraploid karyotypes had also occurred in
three of four cell lines derived from soft-agar colonies formed
by tetraploid POT1a-tetOFF-26 cells (Figure 7C). As a control,
cell lines established from a soft-agar colony and a tumor formed
by diploid cells had a near-diploid karyotype (Figures 7B and 7C).
These results indicate that tetraploid cells generated through
telomere dysfunction have a high rate of chromosome loss.
DISCUSSION
Here, we show that telomere crisis induces tetraploidization in
human fibroblasts and mammary epithelial cells, lending further
credence to the role of telomeres in shaping cancer genomes.
Telomere dysfunction has long been held responsible for the
initiation of breakage-fusion-bridge cycles and their accompa-
nying rearrangements, including nonreciprocal translocations,
regional amplifications, and segmental deletions. The finding
that tetraploidization is an additional corollary of unmitigated
telomere attrition adds to this inventory of telomere-related
genome instability and provides a framework for the genesis of
human tumors carrying heavily rearranged subtetraploid ge-
nomes. Among the potentially pervasive sources of genome
instability in cancer, which include rearrangements originating
from common fragile sites, chromothrypsis, and deficiencies in
double-strand break repair (Durkin and Glover, 2007; Harper
and Elledge, 2007; Negrini et al., 2010; Stephens et al., 2011),
an episode of telomere dysfunction stands out, however, due
its potential aggregate effect. Upon activation of telomerase,
the cells emerging from telomere crisis could potentially com-
bine the mutator phenotype of breakage-fusion-bridge cycles,
the mutational robustness of a tetraploid genome, and the high
chromosome missegregation rate associated with supernumary
centrosomes.
Althoughwe had previously usedmouse embryo fibroblasts to
document endoreduplication after removal of POT1a from
mouse telomeres, it was unclear whether the resulting telomere
dysfunction resembles the molecular events at telomeres that
have become too short after prolonged attrition. For instance,
removal of POT1a from mouse telomeres exposes the single-
stranded DNA and permanently activates the ATR kinase path-
way whereas critically shortened telomeres may be expected
to lose several (or all) shelterin proteins rather than POT1 alone
and are known to activate both ATM and ATR signaling
(d’Adda di Fagagna et al., 2003). It is also unlikely that all telo-
meres in crisis cells become dysfunctional at the same time so
that the overall level of the DNA damage signal elicited by telo-
mere crisis might be less than in the POT1a knockout cells.Cancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc. 773
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generated by POT1a deletion, critically shortened telomeres are
repaired by NHEJ and the resulting damage signal at each
telomere is therefore transient. The current data now clarify
these issues and demonstrate that endoreduplication can be
induced by the DNA damage response to shortened telomeres
as they occur in cells in crisis. Furthermore, the data argue
that this pathway is similar in human and mouse cells, despite
the distinctions in their telomere damage response pathways
(Smogorzewska and de Lange, 2002; Jacobs and de Lange,
2004), and demonstrate the relevance of telomere-driven tetra-
ploidization in epithelial cells, which are a cancer relevant
cell type.
The data indicate that tetraploid mouse cells generated
telomere-driven tetraploidization are more tumorigenic than
their diploid counterparts. This result is consistent with prior
work showing a higher tumorigenic potential of tetraploid cells
generated through the use of a cytokinesis inhibitor (Fujiwara
et al., 2005). In the case of telomere-driven tetraploidization
there is no prolonged arrest in mitosis, no binucleate inter-
mediate is formed, and there is no reorganization of the two
chromosome sets into a tetraploid genome in the next mitosis.
Our findings therefore indicate that the tetraploidization per se
is the most likely source of the greater tumorigenic potential of
the cells.
Order of Events
Telomere-dependent tetraploidization requires a precise se-
quence of events during tumorigenesis. Specifically, both the
p53 and Rb pathways have to be inactivated and the telomeres
have to become sufficiently short to induce telomere crisis
before telomerase is activated. Loss of p53 is required for the
by-pass of telomere-driven senescence and is well-established
as a prerequisite for the proliferation of tetraploid cells (Margolis
et al., 2003; Ganem et al., 2007). The Rb pathway also blocks cell
cycle progression in response to telomere dysfunction and
thereby curbs the emergence and proliferation of tetraploid
descendants (Jacobs and de Lange, 2004). For most human
tumors, there is limited information of the exact order of events
relevant to telomere-driven tetraploidization. In particular, no
prior study has examined indices of tetraploidization, changes
in the status of p53/Rb, and telomerase expression in the
same set of pathological specimen representing different stages
in tumorigenesis. However, for a number of tumor types, it is
known that tetraploidization arises at a stage when both p53
and Rb become inactivated and telomerase is not yet active
(Davoli and de Lange, 2011). Examples include HPV induced
cervical carcinoma, bladder cancer, lung cancer, breast cancer,
and colon cancer. Breast cancer represents a particularly inter-
esting case because there is good evidence for loss of Rb and
p53, telomere crisis, and tetraploidization in DCIS before telome-
rase is activated (Shay and Bacchetti, 1997; Chin et al., 2004;
Ottesen, 2003; Shackney and Silverman, 2003). On the other
hand, there are also several tumor types that express high levels
of telomerase at an early stage (e.g., certain leukemias and
lymphomas) and are therefore unlikely to experience telomere
crisis. Perhaps not surprisingly, these tumors lack the frequent
rearrangements that scar the genomes of solid human tumors
and are mostly near diploid.774 Cancer Cell 21, 765–776, June 12, 2012 ª2012 Elsevier Inc.Collectively, these data suggest a general mechanism for tet-
raploidization in the early stages of human tumorigenesis. When
the p53 and Rb pathway are inactive, extreme telomere short-
ening can induce tetraploidization through endoreduplication
or mitotic failure in precancerous lesions. Reactivation of telo-
merase (or other mechanisms of telomere maintenance) will
allow the tetraploid clone to expand and evolve into a fully trans-
formed cancerous state. The chromosome instability due to
prior telomere dysfunction and the inherent high rate of chro-
mosome mis-segregation of tetraploid cells may then foster
the evolution of a profoundly rearranged subtetraploid cancer
karyotype.
EXPERIMENTAL PROCEDURES
Cell Culture Procedure and Viral Gene Delivery
BJ (ATCC#: CRL2522) and IMR90 (ATCC#: CCl186) human fibroblasts were
transduced with retroviral vectors expressing SV40-LT, HPV-E6/E7, or
p53175H (p53 dn) as described in (Karlseder et al., 2002; Jacobs and de
Lange, 2004). RPE human retinal pigment epithelial cells were purchased
from ATCC (ATCC#: 2302) and retrovirally infected with pLPC-Puro-SV40-LT
or pRetro-Super-Hygro-p53sh vectors. Human mammary epithelial cell lines
184B and 48RS (Romanov et al., 2001), expressing or not the GSE22 peptide
(GSE), acting as a p53 dominant negative (Garbe et al., 2007) were kindly
provided by Dr. Martha Stampfer. POT1a-tetOFF MEFs cell lines 19 and 26
were derived as described elsewhere (Davoli et al., 2010). POT1a-tetOFF
MEFs, IMR90, BJ, and RPE cells were grown in DMEM (containing 10% of
Medium 199 in the case of BJ cells) supplemented with 10% FBS, 100 U peni-
cillin, 0.1 mg/ml streptomycin, 2 mM L-glutamine. hMEC cells were grown in
MEMG (Lonza) supplemented with isoproterenol (10 mM) and transferrin
(5 mg/ml). Human cells were transduced with FUCCI lentiviral vectors express-
ing mKO2-hCdt1 (red) and mAG-hGeminin (green) (Sakaue-Sawano et al.,
2008), generously provided by Dr. Atsushi Miyawaki. Dr. Pier Giuseppe Pelicci
provided pBabe-Puro-MycER. For retroviral and lentiviral infections, phoenix
cells (retro) or 293T (lenti) cells were transfected with 10–20 mg of the trans-
gene-expressing plasmid (in addition to lentiviral packaging vectors in the
case of 293T). Supernatants were used for two to four infections of 4–6 hr
were performed starting 36 hr after transfection with addition of 2–4 mg/ml of
polybrene. Cells were selected for 4–6 days in the presence of 500 ng/ml of
puromycin or 200 mg/ml of hygromycin. Zeocin (Invitrogen, 100 mg/ml final
concentration) and doxycycline (1–2 mg/ml) were added to the cell culture
medium every 2–3 days.
FACS Analysis and FACS Sorting
DNA content was analyzed by FACS in ethanol-fixed after staining with propi-
dium iodide (PI), using standard procedures. Flow cytometry was performed
using the FACScalibur (Becton Dickinson) and data were analyzed using
FlowJo 8.7.1 software. To calculate the percentage of polyploid cells (DNA
content >4N), cell doublets and sub-G1 apoptotic cells were excluded. Diploid
and tetraploid cells were isolated by sorting for a G1 diploid DNA content or
a G2 tetraploid DNA content using an BD FACSAria-2 cell sorter (BD Bio-
sciences) after incubation with Hoechst 33342 (10 mM, AnaSpec, Inc.) for
30 min. GFP-positive cells expressing H2B-GFP were sorted using the same
instrument.
In Vitro and In Vivo Transformation Assay
For in vitro soft-agar colony forming assay, a bottom layer of 2 ml 0.9% agar in
mediumwas prepared and allow to solidify and cells were seeded in a top layer
of 0.45% agar in medium at a density of 104 cells per well in 6-well dishes (trip-
licates were made for each cell line in each experiment). Cells were incubated
at 37C (mediumwas added periodically) and colonies formed after 4–6 weeks
were scored. In the indicated cases, 0.5 nM 4-hydroxytamoxifen (4-OHT,
Sigma) was added to the top layer. In vivo tumorigenic assay was performed
by subcutaneous injection in nude mice. Diploid or tetraploid POT1a-tetOFF-
19 or -26 cells (53 105) were resuspended in PBS and injected into the contra-
lateral sides of NCR-Foxn1nu/nu femalemice (Taconic). The recipient micewere
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Telomere Crisis Induces Tetraploidizationchecked once or twice a week for tumor formation and euthanized when
tumors reached 1 cm diameter, in accordance with institutional procedures.
Tumors were dissociated into single cells by treatment with collagenase A at
250 units/ml in DMEM for 3 hr at 37C. Cells were then washed repeatedly
and plated in 10 cm dishes. All experiments involving mice were performed
in accordance with institutional regulations and ethical guidelines, and have
been authorized by the Institutional Animal Care and Use Committee at
Rockefeller University.
Immunofluorescence, Fluorescence In Situ Hybridization-
Immunofluorescence, and Immunoblotting
Immunofluorescence (IF) and fluorescence in situ hybridization (FISH)-IF on
coverslips and telomeric FISH on metaphase spreads were performed as
described previously (Celli and de Lange, 2005). Briefly, after fixation, cells
on coverslips were blocked in for 30 min in blocking solution (PBS with
0.1% Triton X-100, 1 mM EDTA, 3% goat serum, and 1 mg/ml BSA). Cells
were then incubated for 1 hr with primary antibody diluted in blocking solution
(anti-53BP1, 100-304-A, Novus Biologicals; anti-centrin2, sc-27793-R, Santa
Cruz), washed three times in PBS and incubated with Rhodamine Red-X or
Alexa Fluor 488 conjugated secondary antibody. Finally cells were washed
in PBS and the DNA was counterstained with DAPI. In the case of IF-FISH or
FISH onmetaphase spreads, cells or slides with metaphases were dehydrated
in ethanol and hybridized with PNA-probe FITC-OO-(AATCCC)3 (Applied
Biosystems) in hybridizing solution (70% formamide, 10 mM Tris-HCl
[pH 7.2], 1 mg/ml blocking reagent [Roche]). After denaturation (10 min at
80C), hybridization was performed at room temperature for 2 hr, followed
by two washes for 15 min with washing solution (70% formamide, 10 mM
Tris-HCl [pH 7.2]). Finally cells or metaphase spreads were washed in PBS
and DNA was then counterstained with DAPI. Digital images were captured
with a Zeiss Axioplan II microscope using Improvision OpenLab software.
Immunoblotting was performed as described in (Celli and de Lange, 2005)
with the following antibodies were used: Chk2 (611570, BD Biosciences);
Chk1, P-S317 (A300-163A, Bethyl) for human cells; Chk1 pS345 (#2348, Cell
Signaling Technology) for mouse cells; b-actin (I-19) (sc-1616, Santa Cruz);
p16 (C-20) (Santa Cruz); POT1a (1221).
Telomere Length Analysis
For genomic blotting, cells were harvested at the indicated PD, DNA was iso-
lated as described (de Lange et al., 1990), digested with AluI and MboI, size-
fractionated on a 0.7% agarose gel and transferred to a Hybond membrane
for hybridization using an 800 bp telomeric DNA probe from pSP73Sty11
labeled with [CCCTAA]3-primed Klenow polymerase and 32P-alpha-dCTP.
Blots were exposed to a phosphorimaging screen and analyzed using Image-
Quant software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and five movies and can be
found with this article online at doi:10.1016/j.ccr.2012.03.044.
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